Indian Acetaminophen Exporters: Complete Supplier Ranking with Market Share — 266 Manufacturers (2026) — TransData Nexus

Q: Who is the largest acetaminophen supplier from India?

GRANULES INDIA LIMITED is the largest acetaminophen exporter from India with a 56.1% market share and export value of $130.1M.

Q: How many acetaminophen suppliers are there in India?

There are 266 active acetaminophen exporters in India, collectively shipping $232.0M worth of acetaminophen across 4,829 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top acetaminophen suppliers from India?

The top 5 acetaminophen suppliers from India — GRANULES INDIA LIMITED, ELYSIUM PHARMACEUTICALS LTD, SRI KRISHNA PHARMACEUTICALS LIMITED, MARKSANS PHARMA LIMITED, ELYSIUM PHARMACEUTICALS LIMITED — together control 79.6% of total acetaminophen export value from India.

Suresh Sormare

Acetaminophen

India Pharmaceutical Trade Intelligence

$232.0M266 Suppliers104 CountriesHS 30049069

ExportsIndia → UNITED STATES73.2%India → CANADA11.2%

ImportsCHINA → India$1.2M MEXICO → India$686.3K

#1 Supplier: GRANULES INDIA #1 Buyer: GRANULES CONSUMER

Acetaminophen Suppliers from India (2026) — 266 Exporters, $232.0M Market | TransData Nexus | TransData Nexus

Who Exports Acetaminophen from India — 266 Suppliers Behind a $232.0M Market

India's acetaminophen export market is supplied by 266 active exporters who collectively shipped $232.0M across 4,829 shipments. GRANULES INDIA LIMITED leads with a 56.1% market share, followed by ELYSIUM PHARMACEUTICALS LTD and SRI KRISHNA PHARMACEUTICALS LIMITED. The top 5 suppliers together control 79.6% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Acetaminophen Suppliers & Exporters — 266 manufacturers, $232.0M export market, top destinations and formulations — Acetaminophen supplier data — 266 exporters · $232.0M market · 4,829 shipmentsTransData Nexus · Indian Customs Data

Top Acetaminophen Exporters from India — Ranked by Export Value

GRANULES INDIA LIMITED is the leading acetaminophen exporter from India, holding a 56.1% share of the $232.0M market across 4,829 shipments from 266 exporters. The top 5 suppliers — GRANULES INDIA LIMITED, ELYSIUM PHARMACEUTICALS LTD, SRI KRISHNA PHARMACEUTICALS LIMITED, MARKSANS PHARMA LIMITED, ELYSIUM PHARMACEUTICALS LIMITED — collectively control 79.6% of total export value, indicating a highly concentrated market. Individual shares are: GRANULES INDIA LIMITED (56.1%), ELYSIUM PHARMACEUTICALS LTD (11.0%), SRI KRISHNA PHARMACEUTICALS LIMITED (5.4%), MARKSANS PHARMA LIMITED (3.7%), ELYSIUM PHARMACEUTICALS LIMITED (3.4%).

Top Acetaminophen Exporters from India

Ranked by export value · 266 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Acetaminophen Exporters from India — Ranked by Export Value. 266 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Acetaminophen — Export Intelligence Video

Visual overview of India's acetaminophen supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's acetaminophen pharmaceutical supplier landscape — $232.0M in total trade, 266 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Acetaminophen exporters

Certification and compliance status for top Acetaminophen suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Granules India Limited	Warning Letter issued in	Unknown	Unknown	69 approvals as of January 2025	FDA cited significant cGMP violations, including inadequate cleaning procedures
Eugia Pharma Specialities Limited	Warning Letter issued in	Unknown	Unknown	Not verified	FDA identified significant cGMP violations during inspection.
Sri Krishna Pharmaceuticals Limited	Warning Letter issued in	Unknown	Unknown	Not verified	FDA cited data manipulation and integrity issues.
Granules Life Sciences Private Limited	Approved in November 2025	Unknown	Unknown	Not verified	Received first FDA approval for Hyderabad facility.
Mylan Laboratories Limited	Warning Letter issued in	Unknown	Unknown	Not verified	FDA cited cGMP violations.
Glenmark Pharmaceuticals Limited	Warning Letter issued in	Unknown	Unknown	Not verified	FDA identified significant cGMP violations.
Global Pharma Healthcare Private Limited	Warning Letter issued in	Unknown	Unknown	Not verified	FDA cited significant cGMP violations.
GPT Pharmaceuticals Private Ltd	Warning Letter issued in	Unknown	Unknown	Not verified	FDA cited significant cGMP violations.

TransData Nexus reviewed the regulatory standing of 8 leading Acetaminophen exporters from India. 1 hold US FDA facility approvals, 0 maintain WHO-GMP certification, and 0 are EU GMP compliant. 7 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Acetaminophen sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for active pharmaceutical ingredients (APIs) production. The city hosts major manufacturers like Granules India Limited and Sri Krishna Pharmaceuticals Ltd. Granules India, headquartered in Hyderabad, operates one of the world's largest paracetamol facilities in Visakhapatnam, with an annual capacity exceeding 30,000 metric tons. This facility's backward integration into key raw materials like para-aminophenol (PAP) minimizes supply chain risks and enhances cost efficiency. Similarly, Sri Krishna Pharmaceuticals, established in 1974, began as a pioneer in bulk acetaminophen manufacturing and has grown into a vertically integrated producer of multiple first-line-of-defense APIs.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations industry. This region is home to over 3,300 pharmaceutical units, making it one of India's largest pharmaceutical manufacturing clusters. Companies in this area focus on producing finished dosage forms, including tablets and capsules containing acetaminophen, catering to both domestic and international markets. The well-established infrastructure and regulatory compliance in this region make it a preferred destination for pharmaceutical formulations.

Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Acetaminophen exporters from India

October 2022

Capacity Expansion

Marksans Pharma Limited — Marksans Pharma acquires Tevapharm India's Goa facility

Marksans Pharma entered into a Business Transfer Agreement with Tevapharm India Private Limited to acquire its bulk pharmaceutical formulations manufacturing facility in Verna, Goa. The site holds approvals from the European Union, Health Canada, and the Japanese Health Authority. - IMPACT: This acquisition is expected to double Marksans Pharma's manufacturing capacity, potentially enhancing their acetaminophen production capabilities.

Impact: This acquisition is expected to double Marksans Pharma's manufacturing capacity, potentially enhancing their acetaminophen production capabilities.

August 2023

Regulatory Approval

Marksans Pharma Limited — Marksans Pharma receives US FDA approval for Guaifenesin Extended-Release Tablets

The company received final approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Guaifenesin Extended-Release Tablets, 600 mg and 1200 mg (OTC), bioequivalent to Mucinex Extended-Release Tablets. - IMPACT: While this approval pertains to Guaifenesin, it demonstrates Marksans Pharma's expanding presence in the US market, which may indirectly influence their acetaminophen export strategies.

Common Questions — Acetaminophen Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which acetaminophen supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, GRANULES INDIA LIMITED leads with 1,700 recorded shipments worth $130.1M. ELYSIUM PHARMACEUTICALS LTD (390 shipments) and SRI KRISHNA PHARMACEUTICALS LIMITED (138 shipments) are also established high-volume exporters.

Q How many acetaminophen manufacturers are there in India?

India has 266 active acetaminophen exporters with a combined export market of $232.0M across 4,829 shipments to 104 countries. The top 5 suppliers hold 79.6% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for acetaminophen from India?

Average FOB unit price: $17.97 per unit, ranging from $0.00 to $709.13. Average shipment value: .

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Acetaminophen

Acetaminophen

Who Exports Acetaminophen from India — 266 Suppliers Behind a $232.0M Market

Top Acetaminophen Exporters from India — Ranked by Export Value

Top Acetaminophen Exporters from India

Related Analysis

Need Details?

Acetaminophen — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Marksans Pharma Limited — Marksans Pharma acquires Tevapharm India's Goa facility

Marksans Pharma Limited — Marksans Pharma receives US FDA approval for Guaifenesin Extended-Release Tablets

Common Questions — Acetaminophen Suppliers from India

Q Which acetaminophen supplier from India is the most reliable for bulk orders?

Q How many acetaminophen manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for acetaminophen from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Marksans Pharma Limited — Marksans Pharma receives US FDA approval for Esomeprazole Magnesium Delayed-Release Capsules

Analysis Methodology